Radiology, Vol 191, 675-680, Copyright © 1994 by Radiological Society of North America

ARTICLES

Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment

M Remy-Jardin, F Giraud, J Remy, L Wattinne, B Wallaert and A Duhamel
Department of Radiology, Hopital Calmette, Lille, France.

PURPOSE: To investigate the role of computed tomography (CT) in determining disease activity and functional impairment and in predicting the prognosis of lung involvement in patients with sarcoidosis. MATERIALS AND METHODS: Two groups of patients underwent CT, pulmonary function tests, and bronchoalveolar lavage. Disease activity was based on serum angiotensin converting enzyme activity and/or lymphocytosis at bronchoalveolar lavage. CT findings in group 1 were correlated with indexes of disease activity and functional parameters at diagnosis. In group 2, evaluation initially and at follow- up led to investigation of correlations between initial CT findings and evolution of disease activity and functional impairment. RESULTS: CT abnormalities in group 1 were nodules, air-space consolidation, lung distortion, septal and nonseptal linear areas of high attenuation, ground-glass attenuation, and honeycombing. Profusion of septal lines was the only CT finding that correlated with disease activity. Statistically significant (P < .05) but low correlation (r < .48) was observed between the extent of abnormalities at CT and impairment of lung function, except for nodules. CONCLUSION: Profusion of lung changes reflects functional impairment but not disease activity. CT findings cannot help predict the evolution of lung changes over time.

This article has been cited by other articles:

				H. Terasaki, K. Fujimoto, N. L. Muller, J. Sadohara, M. Uchida, T. Koga, H. Aizawa, and N. Hayabuchi Pulmonary Sarcoidosis: Comparison of Findings of Inspiratory and Expiratory High-Resolution CT and Pulmonary Function Tests Between Smokers and Nonsmokers Am. J. Roentgenol., August 1, 2005; 185(2): 333 - 338. [Abstract] [Full Text] [PDF]

				M. Akira, T. Kozuka, Y. Inoue, and M. Sakatani Long-term Follow-up CT Scan Evaluation in Patients With Pulmonary Sarcoidosis Chest, January 1, 2005; 127(1): 185 - 191. [Abstract] [Full Text] [PDF]

				S B Shaker, T Stavngaard, J Stolk, B Stoel, and A Dirksen {alpha}1-Antitrypsin deficiency {middle dot} 7: Computed tomographic imaging in {alpha}1-antitrypsin deficiency Thorax, November 1, 2004; 59(11): 986 - 991. [Abstract] [Full Text] [PDF]

				L. B. Haramati, G. Lee, A. Singh, P. L. Molina, and C. S. White Newly Diagnosed Pulmonary Sarcoidosis in HIV-infected Patients Radiology, January 1, 2001; 218(1): 242 - 246. [Abstract] [Full Text]

				M. Abehsera, D. Valeyre, P. Grenier, H. Jaillet, J. P. Battesti, and M. W. Brauner Sarcoidosis with Pulmonary Fibrosis: CT Patterns and Correlation with Pulmonary Function Am. J. Roentgenol., June 1, 2000; 174(6): 1751 - 1757. [Abstract] [Full Text]

				M. Gaeta, A. Blandino, E. Scribano, F. Minutoli, M. Barone, F. Ando, and I. Pandolfo Chronic Infiltrative Lung Diseases: Value of Gadolinium-Enhanced MRI in the Evaluation of Disease Activity--Early Report Chest, April 1, 2000; 117(4): 1173 - 1178. [Abstract] [Full Text] [PDF]

				M. CASARINI, F. AMEGLIO, L. ALEMANNO, P. ZANGRILLI, P. MATTIA, G. PAONE, A. BISETTI, and S. GIOSUÈ Cytokine Levels Correlate with a Radiologic Score in Active Pulmonary Tuberculosis Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 143 - 148. [Abstract] [Full Text]

				S. GIOSUE, M. CASARINI, L. ALEMANNO, G. GALLUCCIO, P. MATTIA, G. PEDICELLI, L. REBEK, A. BISETTI, and F. AMEGLIO Effects of Aerosolized Interferon-alpha in Patients with Pulmonary Tuberculosis Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1156 - 1162. [Abstract] [Full Text] [PDF]

				R M du Bois Recent Advances: Respiratory medicine BMJ, June 17, 1995; 310(6994): 1594 - 1597. [Full Text]